IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.
Source: MarketWatch
Friday, 10. January 2025
Share:
09. January 2025 20:27
IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out
